Foley Of Counsel Donna Bucella, Partner Gregory Neppl and Associate Christina Kennedy authored an article titled “Brussels muscle,” that appeared in the January 22, 2010 issue of The Deal. The authors discuss the appointment of international adviser Rachel Brandenburger by the Justice Department’s Antitrust Division, stating that the appointment may be a sign of the times as antitrust authorities are increasingly confronted with global issues. They add that the Justice Department’s hiring of Brandenburger is a step towards improved cooperation among international trust agencies.
Author(s)
Related Insights
09 December 2024
Events
Milwaukee CLE Week 2024
We are excited to announce Foley's Annual Milwaukee CLE Week! This year's program will feature three days of in-person sessions, focusing on essential business, industry, and ethics topics.
23 October 2024
Health Care Law Today
Private Equity Investments in Oncology: Top Five Things to Know
Although private equity (PE) sponsors have been active investors in the health care services industry for the last decade, PE-backed health care providers today constitute only 4% of the United States health market by revenue.
23 October 2024
Health Care Law Today
GLP-1 Drugs: FDA Sued Over Removing Tirzepatide from the Drug Shortage List
Less than a week after the FDA determined that the shortage of the tirzepatide injection, a glucagon-like peptide 1 (GLP-1) medication, has been “resolved” and removed from the FDA’s shortage list, the Outsourcing Facilities Association filed a lawsuit against the FDA relating to the agency’s removal of tirzepatide, from the FDA’s drug shortage list.